[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 25 days · First seen · Last updated

Institutional short selling of LANXESS

Overview

Institutional investors have been steadily increasing their short positions in the German company LANXESS.

In July 2026, LANXESS shares saw a modest rise to €15.39 despite Bridgewater Associates increasing its net short position from 0.49% to 0.53% of the free float. At that time, BlackRock Investment Management (UK) led other institutional short holders with a 2.35% stake. This activity followed a period of decline for the stock, which had recently reported a revenue decline of 13.9% and a loss of €1.63 per share.

By mid-August 2026, Bridgewater Associates further expanded its net short position from 0.61% to 0.70%. During this same period, BlackRock’s presence in the short side of the stock was noted through various entities, including BlackRock Investment Management (UK) Limited holding a 1.94% position.

Entities

Lanxess · Carl Zeiss Meditec AG · Millennium International Management LP · SMA Solar Technology · AQR Capital Management, LLC

Timeline

  1. 27 days ago

    [BUSINESS] 4 sources
    Carl Zeiss Meditec implements cost-cutting measures amid declining revenue

    Carl Zeiss Meditec is implementing a ‘ProfitUp’ program to cut costs by €200 million and reduce staff by up to 700, amid declining revenues and increased short-selling from firms like Citadel and Millennium.

  2. about 2 months ago

    [BUSINESS] 3 sources
    LANXESS shares rise modestly as Bridgewater expands short position

    LANXESS stock rose 0.92% to €15.39 as Bridgewater lifted its short stake to 0.53%, joining other funds with sizable shorts; the share stays well below its 52‑week high amid recent losses.

Sources

aktiencheck.de · blackout-news.de · joroistenlehti.fi · m.aktiencheck.de